Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Myers

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Biorxiv : the Preprint Server for Biology|May 8, 2026
Functional characterization of the 9q34.13 locus identifies <i>RAPGEF1</i> as modulating risk for melanoma and nevi via RAS activationRohit Thakur, Mai Xu, Alexandra M Thornock, et al.
Human Genetics|January 25, 2012
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang, Hemang Parikh, Jinping Jia, et al.
Human Molecular Genetics|January 10, 2012
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancerWei Tang, Yi-Ping Fu, Jonine D Figueroa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locusAidan O'Brien, Hyunkyung Kong, Harsh Patel, et al.
Research Square|May 25, 2026
A high-penetrance intergenic variant at 9p21 confers melanoma susceptibilityMaria Teresa Landi, Linh Bui-Raborn, Lorenza Pastorino, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Biorxiv : the Preprint Server for Biology|May 8, 2026
Functional characterization of the 9q34.13 locus identifies <i>RAPGEF1</i> as modulating risk for melanoma and nevi via RAS activationRohit Thakur, Mai Xu, Alexandra M Thornock, et al.
Human Genetics|January 25, 2012
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang, Hemang Parikh, Jinping Jia, et al.
Human Molecular Genetics|January 10, 2012
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancerWei Tang, Yi-Ping Fu, Jonine D Figueroa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locusAidan O'Brien, Hyunkyung Kong, Harsh Patel, et al.
Research Square|May 25, 2026
A high-penetrance intergenic variant at 9p21 confers melanoma susceptibilityMaria Teresa Landi, Linh Bui-Raborn, Lorenza Pastorino, et al.
Pageof 3